A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness
Completed · Phase 3
Conditions studied: Ocular Redness
In brief
The purpose of this study is to assess the safety and efficacy of Apraclonidine Hydrochloride Ophthalmic Solution 0.125% when compared to Vehicle, in relieving redness of the eye due to minor eye irritations. This study will be conducted in the United States.
Key facts
- Study ID
- NCT06444529
- Run by
- Alcon Research
- People needed
- 159
- Starts
- 2024-08-21
- Expected to finish
- 2025-01-08
- Last updated by the study team
- 2025-10-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Global Research Management — Glendale, California, United States
- Oculus Research, Inc. — Garner, North Carolina, United States
- Scott & Christie and Associates, PC — Cranberry Township, Pennsylvania, United States
- Emerson Clinical Research Institute, Inc. — Falls Church, Virginia, United States
- Piedmont Eye Center — Lynchburg, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.